| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 30-Sep-07 | | Total Revenue | 10,051 | 27,888 | 31,914 | | Cost of Revenue | 2,618 | 4,151 | 2,251 | | | Gross Profit | 7,433 | 23,737 | 29,664 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 950 | 1,447 | 690 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 6,483 | 22,291 | 28,973 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (133,985) | (113,781) | (49,834) | | Earnings Before Interest And Taxes | 6,483 | 5,877 | 4,264 | | Interest Expense | 621 | 594 | 236 | | Income Before Tax | 5,862 | 5,282 | 4,028 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (128,122) | (92,085) | (21,097) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (128,122) | (92,085) | (21,097) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($128,122) | ($92,085) | ($21,097) |
|
0.22% Nasdaq 
Income Statement
